No profile data available.
Aytu BioPharma, Inc. (AYTU) is a healthcare company in the brain and nerve treatment drugs industry, based in Denver, United States, with about 75 full-time employees.
It reported revenue of $57.57 million for fiscal year 2026, down 13.3% from fiscal year 2025, and net income of -$14.25 million. Its market capitalization was $22.01 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended June 30, 2026; market data as of October 9, 2026.
, a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally.
Aytu BioPharma reported $57.57 million in revenue for fiscal year 2026, down 13.3% from $66.38 million in fiscal year 2025.
$22.01 million as of October 9, 2026.
Listed companies of a similar size in the same industry (brain and nerve treatment drugs) include Quince Therapeutics, Inc. (QNCX), Mira Pharmaceuticals, Inc. (MIRA), TAO Synergies Inc. (TAOX), Psyence Biomedical Ltd. (PBM).